{"id":"W2909436531","doi":"10.2217/cer-2018-0073","title":"A cost–utility analysis of dulaglutide versus insulin glargine as third-line therapy for Type 2 diabetes in Canada","year":2019,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Insulin glargine; Dulaglutide; Type 2 diabetes; Diabetes mellitus; Internal medicine; Insulin; Exenatide; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00414371,0.001324503,0.002140458,0.001887462,0.0007432777,0.001910684,0.001764158,0.0009353707,0.00387566],"category_scores_gemma":[0.01434755,0.0006100985,0.004100434,0.002776709,0.0006755022,0.0005920564,0.0009456934,0.001329901,0.0001396807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05676259,"about_ca_system_score_gemma":0.04313709,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9032263,"about_ca_topic_score_gemma":0.8468756,"domain_scores_codex":[0.9975302,0.001402214,0.000109476,0.0001938018,0.0004038887,0.0003605161],"domain_scores_gemma":[0.9948861,0.003203101,0.0004365862,0.00009912397,0.0009683668,0.0004067964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.02654868,0.0008613155,0.0655978,0.005718661,0.01325439,0.0007890665,0.0001907735,0.8106299,0.0009915743,0.009530711,0.01016569,0.05572142],"study_design_scores_gemma":[0.009792746,0.004358575,0.0830577,0.001553312,0.01601057,0.0004449809,0.0007197353,0.8707832,0.0006764721,0.005587079,0.00668578,0.0003299069],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9147478,0.0322841,0.007414722,0.004285027,0.0001800094,0.002653513,0.02328664,0.0001707481,0.01497746],"genre_scores_gemma":[0.9885156,0.003585622,0.00323619,0.0002980166,0.00002161888,0.0002629292,0.002857289,0.00001562007,0.001207005],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09677368,"threshold_uncertainty_score":0.4118434,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1614136600299384,"score_gpt":0.457361692122425,"score_spread":0.2959480320924865,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}